P

Inventor

VANDERSLICE PETER

US12 patents
⚠️ This page may combine multiple inventors who share the name “VANDERSLICE PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

7 Hills Pharma LLC

4 patents
US11311619B2Apr 26, 2022

Integrin activator vaccine compositions

7 Hills Pharma LLC2 citations70
US10716849B2Jul 21, 2020

Methods of administering novel integrin activator vaccine compositions

7 Hills Pharma LLC3 citations70
US10709780B2Jul 14, 2020

Integrin activator vaccine compositions

7 Hills Pharma LLC3 citations70
US10709781B2Jul 14, 2020

Integrin activator checkpoint inhibitor compositions

7 Hills Pharma LLC2 citations70

TEXAS BIOTECHNOLOGY CORP

3 patents
US5510332AApr 23, 1996

Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor

TEXAS BIOTECHNOLOGY CORP151 citations97
US6087330AJul 11, 2000

Process to inhibit binding of the integrin α4 β1 to VCAM-1 or fibronectin and cyclic peptides therefor

TEXAS BIOTECHNOLOGY CORP33 citations91
US6713604B1Mar 30, 2004

Process to inhibit binding of the integrin α4β1 , to VCAM-1 fibronectin and cyclic peptides thereof

TEXAS BIOTECHNOLOGY CORP7 citations72

7 HILLS INTERESTS LLC

1 patent
US10342866B2Jul 9, 2019

Compositions and methods for immunotherapies comprising small molecule integrin receptor-ligand agonist adjuvants

7 HILLS INTERESTS LLC5 citations79

BIEDIGER RONALD J

1 patent
US9512109B2Dec 6, 2016

Agonists that enhance binding of integrin-expressing cells to integrin receptors

BIEDIGER RONALD J4 citations68

7 HILLS PHARMA INC

1 patent
US12201686B2Jan 21, 2025

Compositions including a therapeutic antibodies and/or a checkpoint inhibitor and an integrin activating compound

7 HILLS PHARMA INC0 citations54

TEXAS HEART INST

1 patent
US10287264B2May 14, 2019

Agonists that enhance binding of integrin-expressing cells to integrin receptors

TEXAS HEART INST0 citations48

TEXAS CHILDRENS HOSPTIAL

1 patent
US11312685B2Apr 26, 2022

Targeting nanoparticles

TEXAS CHILDRENS HOSPTIAL0 citations38